[
  {
    "ts": null,
    "headline": "CURE: Analysts Strike A Cautious Tone Heading Into 2026",
    "summary": "Discover why the Direxion Healthcare Bull 3X ETF is outperforming in 2025. Learn about key risks, returns, and buy ratings.",
    "url": "https://finnhub.io/api/news?id=a5ef5754831c30f25c83c66be5e038c5194b41554790fb800b0ad9b7a81a6a4b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764174517,
      "headline": "CURE: Analysts Strike A Cautious Tone Heading Into 2026",
      "id": 137615429,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2009808479/image_2009808479.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Discover why the Direxion Healthcare Bull 3X ETF is outperforming in 2025. Learn about key risks, returns, and buy ratings.",
      "url": "https://finnhub.io/api/news?id=a5ef5754831c30f25c83c66be5e038c5194b41554790fb800b0ad9b7a81a6a4b"
    }
  },
  {
    "ts": null,
    "headline": "Pediatric Interventional Cardiology Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue",
    "summary": "The Pediatric Interventional Cardiology Market is poised for significant growth, projected to rise from USD 2.42 billion in 2024 to USD 4.34 billion by 2033, exhibiting a 6.68% CAGR. This expansion is driven by the increasing prevalence of congenital heart defects such as VSD, PDA, and ASD in children. The advent of advanced medical devices and the shift towards non-invasive treatments also contribute to market growth. The U.S. stands out as a key player due to rising infant cardiac abnormalitie",
    "url": "https://finnhub.io/api/news?id=0bd004e3b7793f9aa450455a0c4998cfeccc2f008ca22517f85a97c00639ab17",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764152760,
      "headline": "Pediatric Interventional Cardiology Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue",
      "id": 137611361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Pediatric Interventional Cardiology Market is poised for significant growth, projected to rise from USD 2.42 billion in 2024 to USD 4.34 billion by 2033, exhibiting a 6.68% CAGR. This expansion is driven by the increasing prevalence of congenital heart defects such as VSD, PDA, and ASD in children. The advent of advanced medical devices and the shift towards non-invasive treatments also contribute to market growth. The U.S. stands out as a key player due to rising infant cardiac abnormalitie",
      "url": "https://finnhub.io/api/news?id=0bd004e3b7793f9aa450455a0c4998cfeccc2f008ca22517f85a97c00639ab17"
    }
  },
  {
    "ts": null,
    "headline": "US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad",
    "summary": "The United States STD Diagnostics Market is set to grow from US$ 5.06 billion in 2024 to US$ 8.49 billion by 2033, achieving a CAGR of 5.91% from 2025 to 2033. Key growth drivers include rising STD prevalence, technological advancements, increased awareness, and supportive government initiatives. Rapid point-of-care tests and molecular diagnostics are gaining traction, while high costs and regulatory hurdles persist as challenges. Major markets like California, Texas, New York, and Florida lead",
    "url": "https://finnhub.io/api/news?id=8543e594ef4f6888b8a60fd6caa1d759c601038a6cd2405c9742a3e70a98035d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764152220,
      "headline": "US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad",
      "id": 137611362,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The United States STD Diagnostics Market is set to grow from US$ 5.06 billion in 2024 to US$ 8.49 billion by 2033, achieving a CAGR of 5.91% from 2025 to 2033. Key growth drivers include rising STD prevalence, technological advancements, increased awareness, and supportive government initiatives. Rapid point-of-care tests and molecular diagnostics are gaining traction, while high costs and regulatory hurdles persist as challenges. Major markets like California, Texas, New York, and Florida lead",
      "url": "https://finnhub.io/api/news?id=8543e594ef4f6888b8a60fd6caa1d759c601038a6cd2405c9742a3e70a98035d"
    }
  },
  {
    "ts": null,
    "headline": "CMS covers cardiac ablation in ambulatory surgery centers",
    "summary": "Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.",
    "url": "https://finnhub.io/api/news?id=6d440735b566829ab45e64cd097b3e653a62f1a7d2d3619242969edc52973bdc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764151131,
      "headline": "CMS covers cardiac ablation in ambulatory surgery centers",
      "id": 137614465,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.",
      "url": "https://finnhub.io/api/news?id=6d440735b566829ab45e64cd097b3e653a62f1a7d2d3619242969edc52973bdc"
    }
  },
  {
    "ts": null,
    "headline": "Is Abbott Laboratories Stock Underperforming the S&P 500?",
    "summary": "Abbott Laboratories has lagged behind the S&P 500 in recent months as well as over the past year, yet analysts remain strongly bullish on the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=4e199b3f0c6728b893199450bb521bd6f6242cf2ae2d52d33d4edc6de2148bbd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764149904,
      "headline": "Is Abbott Laboratories Stock Underperforming the S&P 500?",
      "id": 137611363,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories has lagged behind the S&P 500 in recent months as well as over the past year, yet analysts remain strongly bullish on the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=4e199b3f0c6728b893199450bb521bd6f6242cf2ae2d52d33d4edc6de2148bbd"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Valuation in Focus After Renewed Trading Momentum",
    "summary": "Abbott Laboratories (ABT) stock has caught the attention of investors after recent trading momentum shifted slightly upward this week. This move comes on the back of moderate gains over the past month, encouraging some renewed interest in the healthcare giant. See our latest analysis for Abbott Laboratories. This week’s upward momentum follows what has been a solid stretch for Abbott Laboratories, underscoring renewed optimism after a year of moderate but positive performance. While the share...",
    "url": "https://finnhub.io/api/news?id=24125488905baa266ba696608714855ce054a25c2f784a34c24b19d9089e5f4b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764148849,
      "headline": "Abbott Laboratories (ABT) Valuation in Focus After Renewed Trading Momentum",
      "id": 137611364,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (ABT) stock has caught the attention of investors after recent trading momentum shifted slightly upward this week. This move comes on the back of moderate gains over the past month, encouraging some renewed interest in the healthcare giant. See our latest analysis for Abbott Laboratories. This week’s upward momentum follows what has been a solid stretch for Abbott Laboratories, underscoring renewed optimism after a year of moderate but positive performance. While the share...",
      "url": "https://finnhub.io/api/news?id=24125488905baa266ba696608714855ce054a25c2f784a34c24b19d9089e5f4b"
    }
  }
]